Benapryzine

Benapryzine (BANTooltip British Approved Name), or benaprizine (INNTooltip International Nonproprietary Name), also known as benapryzine hydrochloride (USANTooltip United States Adopted Name in the case of the hydrochloride salt and sold under the brand name Brizin, is an antiparkinsonian agent and anticholinergic which has been used in the treatment of parkinsonism.^[2][3][4][1] As an anticholinergic, it is specifically a muscarinic acetylcholine receptor antagonist.^[1] Structurally, benapryzine is a benzilate, and is closely related to other antimuscarinic benzilate derivatives like benactyzine.^[4] The drug was first described in the literature by 1973.^[2][5]

Trade namesBrizin

Other namesBenapryzine; Beneprizine; Benepryzine; BRL-1288; BRL1288; AP-1288; AP1288

Routes of
administrationOral^[1]

CAS Number

• 22487-42-9
  3202-55-9 (hydrochloride)

Quick facts Clinical data, Trade names ...

Benapryzine

Clinical data
Trade names	Brizin
Other names	Benapryzine; Beneprizine; Benepryzine; BRL-1288; BRL1288; AP-1288; AP1288
Routes of administration	Oral[1]
Identifiers
IUPAC name 2-[ethyl(propyl)amino]ethyl 2-hydroxy-2,2-diphenylacetate
CAS Number	22487-42-9 3202-55-9 (hydrochloride)
PubChem CID	18551
ChemSpider	17520
UNII	14FPC4V3AX
ChEBI	CHEBI:191253
ChEMBL	ChEMBL2110766
CompTox Dashboard (EPA)	DTXSID00865055
Chemical and physical data
Formula	C21H27NO3
Molar mass	341.451 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCCN(CC)CCOC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O
InChI InChI=1S/C21H27NO3/c1-3-15-22(4-2)16-17-25-20(23)21(24,18-11-7-5-8-12-18)19-13-9-6-10-14-19/h5-14,24H,3-4,15-17H2,1-2H3 Key:PYPJRLVCFAVWFR-UHFFFAOYSA-N

Close